Skip to main content

Table 3 Comparison of respondents to non-respondents in a survey of Utah cancer survivors1,2

From: The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures

 

Full sample

Paper

Web

Non-respondents

Respondents

 

Non-respondents

Respondents

 

Non-respondents

Respondents

 

n

%

n

%

P

n

%

n

%

P

n

%

n

%

P

Time since diagnosis

0.022

    

0.144

    

0.076

 Long-term

114

59.4

78

40.6

 

53

55.2

43

44.8

 

61

63.5

35

36.5

 

 Recent

123

48.4

131

51.6

 

59

45.4

71

54.6

 

64

51.6

60

48.4

 

Sex

0.130

    

0.016

    

0.760

 Female

126

50.0

126

50.0

 

55

42.6

74

57.4

 

71

57.7

52

42.3

 

 Male

111

57.2

83

42.8

 

57

58.8

40

41.2

 

54

55.7

43

44.3

 

Current age

0.028

    

0.223

    

0.139

  < 40

47

63.5

27

36.5

 

21

60.0

14

40.0

 

26

66.7

13

33.3

 

 40–49

62

49.2

64

50.8

 

34

50.0

34

50.0

 

28

48.3

30

51.7

 

 50–59

97

56.7

74

43.3

 

42

51.2

40

48.8

 

55

61.8

34

38.2

 

  > =60

31

41.3

44

58.7

 

15

36.6

26

63.4

 

16

47.1

18

52.9

 

Race

0.055

    

0.558

    

0.040

 White

216

51.9

200

48.1

 

104

49.1

108

50.9

 

112

54.9

92

45.1

 

 Nonwhite

21

70.0

9

30.0

 

8

57.1

6

42.9

 

13

81.3

< 53

–

 

Ethnicity

0.020

    

0.439

    

0.011

 Hispanic

45

66.2

23

33.8

 

19

55.9

15

44.1

 

26

76.5

8

23.5

 

 Non-Hispanic

189

50.8

183

49.2

 

92

48.7

97

51.3

 

97

53.0

86

47.0

 

Geography

0.909

    

0.904

    

0.874

 Rural

32

52.5

29

47.5

 

18

48.7

19

51.4

 

14

58.3

10

41.7

 

 Metro-politan

205

53.3

180

46.8

 

94

49.7

95

50.3

 

111

56.6

85

43.4

 

Cancer site

0.144

    

0.074

    

0.728

 Colorectal

77

60.2

51

39.8

 

37

58.7

26

41.3

 

40

61.5

25

38.5

 

 Myeloma

31

48.4

33

51.6

 

12

37.5

20

62.5

 

19

59.4

13

40.6

 

 Breast

51

52.6

46

47.4

 

24

47.1

27

52.9

 

27

58.7

19

41.3

 

 Ovarian

26

41.3

37

58.7

 

11

34.4

21

65.6

 

15

48.4

16

51.6

 

 Prostate

52

55.3

42

44.7

 

28

58.3

20

41.7

 

24

52.2

22

47.8

 

Stage

0.174

    

0.162

    

0.652

 In situ

10

41.7

14

58.3

 

< 53

–

7

70.0

 

7

50.0

7

50.0

 

 Localized

118

55.9

93

44.1

 

57

51.4

54

48.7

 

61

61.0

39

39.0

 

 Regional

65

57.0

49

43.0

 

32

58.2

23

41.8

 

33

55.9

26

44.1

 

 Distant

44

45.4

53

54.6

 

20

40.0

30

60.0

 

24

51.1

23

48.9

 
  1. 1. Percent of respondents equates to response rate
  2. 2. P-values for statistically significant comparisons are presented in boldface.
  3. 3. Cell counts less than five are masked for protection of confidentiality